Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition.

drug protocol number
42767
drug sponsor
SPIMACO ADDWAEIH
drug study
solifenacin succinate
drug trial site
Saudi Ajal
drug status
Ongoing
drug phase